Literature DB >> 28493222

[Twelve years of the S3 guideline Fibromyalgia Syndrome-a never-ending war?]

W Häuser1, E Kühn2, B Wolf3, M Nothacker4, F Petzke5.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28493222     DOI： 10.1007/s00482-017-0219-9

Source DB:  PubMed          Journal:  Schmerz        ISSN： 0932-433X            Impact factor:   1.107


× No keyword cloud information.
  11 in total

Review 1.  [Physiotherapy and physical therapies for fibromyalgia syndrome. Systematic review, meta-analysis and guideline].

Authors:  A Winkelmann; W Häuser; E Friedel; M Moog-Egan; D Seeger; M Settan; T Weiss; M Schiltenwolf
Journal:  Schmerz       Date:  2012-06       Impact factor: 1.107

2.  [Methodological fundamentals of the development of the guideline].

Authors:  W Häuser; K Bernardy; H Wang; I Kopp
Journal:  Schmerz       Date:  2012-06       Impact factor: 1.107

Review 3.  Fibromyalgia wars.

Authors:  Frederick Wolfe
Journal:  J Rheumatol       Date:  2009-04       Impact factor: 4.666

4.  [Treatment and healthcare costs of fibromyalgia syndrome in Germany: analysis of the data of the Barmer health insurance (BEK) from 2008-2009].

Authors:  U Marschall; B Arnold; W Häuser
Journal:  Schmerz       Date:  2011-08       Impact factor: 1.107

5.  [Fibromyalgia syndrome: guideline principle for a fiction?].

Authors:  W Häuser
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

6.  [Methodology report of the 2017 guidelines on fibromyalgia syndrome].

Authors:  W Häuser; M Nothacker
Journal:  Schmerz       Date:  2017-06       Impact factor: 1.107

Review 7.  [Etiology and pathophysiology of fibromyalgia syndrome : Updated guidelines 2017, overview of systematic review articles and overview of studies on small fiber neuropathy in FMS subgroups].

Authors:  N Üçeyler; M Burgmer; E Friedel; W Greiner; F Petzke; M Sarholz; M Schiltenwolf; A Winkelmann; C Sommer; W Häuser
Journal:  Schmerz       Date:  2017-06       Impact factor: 1.107

Review 8.  [Definition, diagnostics and therapy of chronic widespread pain and the (so-called) fibromyalgia syndrome in children and adolescents : Updated guidelines 2017].

Authors:  N Draheim; F Ebinger; E Schnöbel-Müller; B Wolf; W Häuser
Journal:  Schmerz       Date:  2017-06       Impact factor: 1.107

9.  Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population.

Authors:  Frederick Wolfe; Elmar Brähler; Andreas Hinz; Winfried Häuser
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-05       Impact factor: 4.794

10.  Small fibre pathology in patients with fibromyalgia syndrome.

Authors:  Nurcan Üçeyler; Daniel Zeller; Ann-Kathrin Kahn; Susanne Kewenig; Sarah Kittel-Schneider; Annina Schmid; Jordi Casanova-Molla; Karlheinz Reiners; Claudia Sommer
Journal:  Brain       Date:  2013-03-09       Impact factor: 13.501
View more
  1 in total

1.  ["But you've got to do something yourself as well" : Coping with fibromyalgia syndrome (FMS): perspectives of those affected and those treating them in Saarland].

Authors:  Marion Al-Qadi; Dagmar Renaud; Martha Meyer
Journal:  Schmerz       Date:  2020-09-22       Impact factor: 1.107
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.